Clinical trial · Interventional
The Effect of Vaginal Dilator Use
The Effect of Vaginal Dilator Use on Female Sexual Function, Self-Compassion, and Quality of Life in Patients After Gynecological Brachytherapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Objective: This study aimed to investigate the effects of vaginal dilator use on female sexual function, self-compassion level, and quality of life in women undergoing brachytherapy for cervical cancer. Method: The study was conducted using a pre-test post-test quasi-experimental design. The study was conducted with 80 female patients between June 1, 2025, and February 1, 2026. Data were collected using the Patient Identification Form, Self-Compassion Scale-Short Form (SCS-SF), Female Sexual Function Scale (FSFI), and EORTC QLQ-C30. Participants were evaluated at three different time points (week 1, week 4, and week 12).
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brachytherapy | — | UNRESOLVED | — |
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Vaginal dilator | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Vaginal dilator
- description
- All participants received the same intervention (vaginal dilator use), and outcomes were evaluated at multiple time points (1st, 4th, and 12th weeks) to assess changes over time.
- interventionNames
- Other: Vaginal dilator
Primary outcomes (10)
- measure
- Participant Information Form
- timeFrame
- baseline
- description
- The Patient Diagnostic Form used in the study was developed by the researchers in line with the literature and consists of a total of 17 questions. The form consists of three sections: (1) sociodemographic characteristics (age, marital status, education, employment status, etc.), (2) clinical characteristics related to treatment (types of treatment applied, number of brachytherapy sessions and follow-up period), and (3) gynecological and sexual health characteristics (surgical history, menopausal status, vaginal dryness, sexual activity and sexual changes after treatment). In addition, the level of knowledge about vaginal dilator use and perceived contribution were also evaluated.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Women aged 18 years * Diagnosed with cervical cancer * Completed external radiotherapy and brachytherapy * Initiated vaginal dilator use following treatment * Able to communicate and provide informed consent * Voluntarily agreed to participate in the study Exclusion Criteria: * Presence of severe psychiatric or cognitive disorders * Diagnosis of another active malignancy * Severe comorbid conditions that may affect participation * Inability to complete questionnaires or follow the study procedures * Refusal to participate or withdrawal during the study period
References
Publications (0)
Data not yet available